Literature DB >> 2477153

Experimental basis of innovative therapies of rheumatoid arthritis.

J B Shiroky1, D E Yocum, R L Wilder, J H Klippel.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2477153

Source DB:  PubMed          Journal:  Concepts Immunopathol        ISSN： 0255-7983


× No keyword cloud information.
  4 in total

1.  The T-cell-receptor repertoire in the synovial fluid of a patient with rheumatoid arthritis is polyclonal.

Authors:  Y Uematsu; H Wege; A Straus; M Ott; W Bannwarth; J Lanchbury; G Panayi; M Steinmetz
Journal:  Proc Natl Acad Sci U S A       Date:  1991-10-01       Impact factor: 11.205

Review 2.  Molecular and cellular mechanisms of joint destruction in rheumatoid arthritis: two cellular mechanisms explain joint destruction?

Authors:  S Gay; R E Gay; W J Koopman
Journal:  Ann Rheum Dis       Date:  1993-03       Impact factor: 19.103

3.  Pharmacological modulation of rat monocytes: in vivo effects on Ia expression and interleukin-1 production.

Authors:  E J Schenkelaars; H N Singh; R L Goldberg; J R Doughty; J Peppard; G DiPasquale; F Quagliata
Journal:  Agents Actions       Date:  1991-09

4.  Transfer of rheumatoid arthritis into severe combined immunodeficient mice. The pathogenetic implications of T cell populations oligoclonally expanding in the rheumatoid joints.

Authors:  T Mima; Y Saeki; S Ohshima; N Nishimoto; M Matsushita; M Shimizu; Y Kobayashi; T Nomura; T Kishimoto
Journal:  J Clin Invest       Date:  1995-10       Impact factor: 14.808
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.